Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.64 |
| ▸ | MEN1 | O00255 | 5/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.64 |
| ▸ | MAPT | P10636 | 4/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | NT5E | P21589 | 1/20 | 0.52 |
| ▸ | ANTXR2 | P58335 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.50 |
| ▸ | RECQL | P46063 | 3/20 | 0.50 |
| ▸ | BLM | P54132 | 3/20 | 0.50 |
| ▸ | THRB | P10828 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | MAOA | P21397 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | MMP1 | P03956 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10135382 | 0.90 | KDM4E (0.60) | KDM4EMEN1KMT2AMAPTCYP3A4 | |
| SCHEMBL10181612 | 0.85 | KDM4E (0.55) | KDM4EMEN1KMT2AMAPTCYP3A4 | |
| SCHEMBL10181447 | 0.79 | PTGS1 (0.65) | KDM4EMEN1KMT2AMAPTCYP3A4 | |
| SCHEMBL10135387 | 0.79 | KDM4E (0.50) | KDM4EMEN1KMT2AMAPTCYP3A4 | |
| SCHEMBL10181450 | 0.79 | PTGS1 (0.51) | KDM4EMEN1KMT2AMAPTCYP3A4 | |
| SCHEMBL10135385 | 0.78 | MAOA (0.54) | KDM4EMEN1KMT2AMAPTCYP3A4 | |
| SCHEMBL10182556 | 0.78 | NUAK1 (0.56) | KDM4EMEN1KMT2AMAPTCYP3A4 | |
| SCHEMBL581188 | 0.78 | KDM4E (0.59) | KDM4EMEN1KMT2AMAPTCYP3A4 | |
| SCHEMBL580570 | 0.76 | PTGS1 (0.51) | KDM4EMEN1KMT2AMAPTCYP3A4 | |
| SCHEMBL580976 | 0.75 | KDM4E (0.44) | KDM4EMEN1KMT2AMAPTCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2121141-B1 | COUMESTAN-LIKE ANTIOXIDANTS AND UV ABSORBANTS | BASF SE (DE) | 2012-02-15 | — | — | EP | claimed |
| US-20100330009-A1 | COUMESTAN-LIKE ANTIOXIDANTS AND UV ABSORBANTS | CIBA CORPORATION (US) | 2010-12-30 | — | — | US | claimed |
| EP-2121141-A1 | COUMESTAN-LIKE ANTIOXIDANTS AND UV ABSORBANTS | BASF SE (DE) | 2009-11-25 | — | — | EP | claimed |
| WO-2008110465-A1 | COUMESTAN-LIKE ANTIOXIDANTS AND UV ABSORBANTS | BASF SE (CH) | 2008-09-18 | — | — | WO | claimed |
| EP-2464739-B1 | METHODS IN CELL CULTURES, AND RELATED INVENTIONS, EMPLOYING CERTAIN ADDITIVES | BASF SE (DE) | 2016-01-13 | — | — | EP | disclosed |
| US-8859235-B2 | Methods in cell cultures, and related inventions, employing certain additives | BASF SE (DE) | 2014-10-14 | — | — | US | disclosed |
| US-8383088-B2 | Coumestan-like antioxidants and UV absorbants | BASF SE (DE) | 2013-02-26 | — | — | US | disclosed |
| US-8383088-B2 | Coumestan-like antioxidants and UV absorbants | BASF SE (DE) | 2013-02-26 | — | — | US | disclosed |
| US-8383088-B2 | Coumestan-like antioxidants and UV absorbants | BASF SE (DE) | 2013-02-26 | — | — | US | disclosed |
| EP-2121141-B1 | COUMESTAN-LIKE ANTIOXIDANTS AND UV ABSORBANTS | BASF SE (DE) | 2012-02-15 | — | — | EP | disclosed |
| EP-2121141-B1 | COUMESTAN-LIKE ANTIOXIDANTS AND UV ABSORBANTS | BASF SE (DE) | 2012-02-15 | — | — | EP | disclosed |
| WO-2011018472-A2 | METHODS IN CELL CULTURES, AND RELATED INVENTIONS, EMPLOYING CERTAIN ADDITIVES | BASF SE (DE) | 2011-02-17 | — | — | WO | disclosed |
| US-20100330009-A1 | COUMESTAN-LIKE ANTIOXIDANTS AND UV ABSORBANTS | CIBA CORPORATION (US) | 2010-12-30 | — | — | US | disclosed |
| US-20100330009-A1 | COUMESTAN-LIKE ANTIOXIDANTS AND UV ABSORBANTS | CIBA CORPORATION (US) | 2010-12-30 | — | — | US | disclosed |
| US-20100330009-A1 | COUMESTAN-LIKE ANTIOXIDANTS AND UV ABSORBANTS | CIBA CORPORATION (US) | 2010-12-30 | — | — | US | disclosed |
| EP-2121141-A1 | COUMESTAN-LIKE ANTIOXIDANTS AND UV ABSORBANTS | BASF SE (DE) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008110465-A1 | COUMESTAN-LIKE ANTIOXIDANTS AND UV ABSORBANTS | BASF SE (CH) | 2008-09-18 | — | — | WO | disclosed |
| WO-2008110465-A1 | COUMESTAN-LIKE ANTIOXIDANTS AND UV ABSORBANTS | BASF SE (CH) | 2008-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100330009-A1 | COUMESTAN-LIKE ANTIOXIDANTS AND UV ABSORBANTS | TYR, NQO1, SIRT3 | KDM4E 1307/4885MEN1 3538/4885KMT2A 3660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.